The economic burden of medical treatment of children with asthma in China

At present, there are few studies on the economic burden and medical treatment of children with asthma in China. Thus this study aimed to investigate the economic burden of medical treatment of children with asthma in China. The 2015 China Medical Insurance Research Association (CHIRA) database was...

Full description

Saved in:
Bibliographic Details
Published inBMC pediatrics Vol. 20; no. 1; pp. 386 - 11
Main Authors Wu, Ping, Xu, Baoping, Shen, Adong, He, Zonglin, Zhang, Casper J. P., Ming, Wai-kit, Shen, Kunling
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 18.08.2020
BioMed Central
BMC
Subjects
Adolescent
Age groups
Allergens
Ambulatory care facilities
Analysis
Antibiotics
Asthma
Asthma - drug therapy
Child
Child, Preschool
Childhood asthma
Children
China - epidemiology
China medical insurance research association (CHIRA) database
Chronic illnesses
Cities
Cost of Illness
Costs
Cross-Sectional Studies
Economic aspects
Economic burden
Health insurance
Health insurance industry
Hematology
Hospitals
Humans
Infant
Infant, Newborn
Medical economics
National health insurance
Patients
Pediatrics
China
Cities
United States > US
China medical insurance research association (CHIRA) database
Economic burden
Childhood asthma
Online AccessGet full text

Cover

Abstract At present, there are few studies on the economic burden and medical treatment of children with asthma in China. Thus this study aimed to investigate the economic burden of medical treatment of children with asthma in China. The 2015 China Medical Insurance Research Association (CHIRA) database was searched for patients with asthma from 0 to 14 years old. A cross-sectional study with cost analysis was conducted. The annual per capita direct medical cost was RMB 525 (US$75) related to asthma. Totaling 58% of the medical expenditure for asthma was covered by insurance in China, the majority of which were direct medical costs. Those that have the highest rates of using antibiotics were central China (100.0%), children aged 3 years and under (63.6%), as well as fourth-tier and fifth-tier cities (77.1%). Outpatient clinics (98.58% vs 1.42%, P < 0.01), tertiary hospitals (62.08% vs 37.92%, P < 0.01), and general hospitals (72.27% vs 27.73%, P < 0.01) were more often visited than the inpatient clinics, secondary and primary as well as the specialized clinics, respectively. The economic burden of childhood asthma in China is relatively low, and the national medical insurance reduces their economic burden to a large extent. Abuse of antibiotics in treating asthma was found in China. There remain opportunities to strengthen the hierarchical medical system, reducing hospitalization and emergency visits, and ultimately reducing the economic burden of children with asthma.
AbstractList At present, there are few studies on the economic burden and medical treatment of children with asthma in China. Thus this study aimed to investigate the economic burden of medical treatment of children with asthma in China.BACKGROUNDAt present, there are few studies on the economic burden and medical treatment of children with asthma in China. Thus this study aimed to investigate the economic burden of medical treatment of children with asthma in China.The 2015 China Medical Insurance Research Association (CHIRA) database was searched for patients with asthma from 0 to 14 years old. A cross-sectional study with cost analysis was conducted.METHODThe 2015 China Medical Insurance Research Association (CHIRA) database was searched for patients with asthma from 0 to 14 years old. A cross-sectional study with cost analysis was conducted.The annual per capita direct medical cost was RMB 525 (US$75) related to asthma. Totaling 58% of the medical expenditure for asthma was covered by insurance in China, the majority of which were direct medical costs. Those that have the highest rates of using antibiotics were central China (100.0%), children aged 3 years and under (63.6%), as well as fourth-tier and fifth-tier cities (77.1%). Outpatient clinics (98.58% vs 1.42%, P < 0.01), tertiary hospitals (62.08% vs 37.92%, P < 0.01), and general hospitals (72.27% vs 27.73%, P < 0.01) were more often visited than the inpatient clinics, secondary and primary as well as the specialized clinics, respectively.RESULTSThe annual per capita direct medical cost was RMB 525 (US$75) related to asthma. Totaling 58% of the medical expenditure for asthma was covered by insurance in China, the majority of which were direct medical costs. Those that have the highest rates of using antibiotics were central China (100.0%), children aged 3 years and under (63.6%), as well as fourth-tier and fifth-tier cities (77.1%). Outpatient clinics (98.58% vs 1.42%, P < 0.01), tertiary hospitals (62.08% vs 37.92%, P < 0.01), and general hospitals (72.27% vs 27.73%, P < 0.01) were more often visited than the inpatient clinics, secondary and primary as well as the specialized clinics, respectively.The economic burden of childhood asthma in China is relatively low, and the national medical insurance reduces their economic burden to a large extent. Abuse of antibiotics in treating asthma was found in China. There remain opportunities to strengthen the hierarchical medical system, reducing hospitalization and emergency visits, and ultimately reducing the economic burden of children with asthma.CONCLUSIONThe economic burden of childhood asthma in China is relatively low, and the national medical insurance reduces their economic burden to a large extent. Abuse of antibiotics in treating asthma was found in China. There remain opportunities to strengthen the hierarchical medical system, reducing hospitalization and emergency visits, and ultimately reducing the economic burden of children with asthma.
At present, there are few studies on the economic burden and medical treatment of children with asthma in China. Thus this study aimed to investigate the economic burden of medical treatment of children with asthma in China. The 2015 China Medical Insurance Research Association (CHIRA) database was searched for patients with asthma from 0 to 14 years old. A cross-sectional study with cost analysis was conducted. The annual per capita direct medical cost was RMB 525 (US$75) related to asthma. Totaling 58% of the medical expenditure for asthma was covered by insurance in China, the majority of which were direct medical costs. Those that have the highest rates of using antibiotics were central China (100.0%), children aged 3 years and under (63.6%), as well as fourth-tier and fifth-tier cities (77.1%). Outpatient clinics (98.58% vs 1.42%, P < 0.01), tertiary hospitals (62.08% vs 37.92%, P < 0.01), and general hospitals (72.27% vs 27.73%, P < 0.01) were more often visited than the inpatient clinics, secondary and primary as well as the specialized clinics, respectively. The economic burden of childhood asthma in China is relatively low, and the national medical insurance reduces their economic burden to a large extent. Abuse of antibiotics in treating asthma was found in China. There remain opportunities to strengthen the hierarchical medical system, reducing hospitalization and emergency visits, and ultimately reducing the economic burden of children with asthma.
Abstract Background At present, there are few studies on the economic burden and medical treatment of children with asthma in China. Thus this study aimed to investigate the economic burden of medical treatment of children with asthma in China. Method The 2015 China Medical Insurance Research Association (CHIRA) database was searched for patients with asthma from 0 to 14 years old. A cross-sectional study with cost analysis was conducted. Results The annual per capita direct medical cost was RMB 525 (US$75) related to asthma. Totaling 58% of the medical expenditure for asthma was covered by insurance in China, the majority of which were direct medical costs. Those that have the highest rates of using antibiotics were central China (100.0%), children aged 3 years and under (63.6%), as well as fourth-tier and fifth-tier cities (77.1%). Outpatient clinics (98.58% vs 1.42%, P < 0.01), tertiary hospitals (62.08% vs 37.92%, P < 0.01), and general hospitals (72.27% vs 27.73%, P < 0.01) were more often visited than the inpatient clinics, secondary and primary as well as the specialized clinics, respectively. Conclusion The economic burden of childhood asthma in China is relatively low, and the national medical insurance reduces their economic burden to a large extent. Abuse of antibiotics in treating asthma was found in China. There remain opportunities to strengthen the hierarchical medical system, reducing hospitalization and emergency visits, and ultimately reducing the economic burden of children with asthma.
At present, there are few studies on the economic burden and medical treatment of children with asthma in China. Thus this study aimed to investigate the economic burden of medical treatment of children with asthma in China. The 2015 China Medical Insurance Research Association (CHIRA) database was searched for patients with asthma from 0 to 14 years old. A cross-sectional study with cost analysis was conducted. The annual per capita direct medical cost was RMB 525 (US$75) related to asthma. Totaling 58% of the medical expenditure for asthma was covered by insurance in China, the majority of which were direct medical costs. Those that have the highest rates of using antibiotics were central China (100.0%), children aged 3 years and under (63.6%), as well as fourth-tier and fifth-tier cities (77.1%). Outpatient clinics (98.58% vs 1.42%, P < 0.01), tertiary hospitals (62.08% vs 37.92%, P < 0.01), and general hospitals (72.27% vs 27.73%, P < 0.01) were more often visited than the inpatient clinics, secondary and primary as well as the specialized clinics, respectively. The economic burden of childhood asthma in China is relatively low, and the national medical insurance reduces their economic burden to a large extent. Abuse of antibiotics in treating asthma was found in China. There remain opportunities to strengthen the hierarchical medical system, reducing hospitalization and emergency visits, and ultimately reducing the economic burden of children with asthma.
Background At present, there are few studies on the economic burden and medical treatment of children with asthma in China. Thus this study aimed to investigate the economic burden of medical treatment of children with asthma in China. Method The 2015 China Medical Insurance Research Association (CHIRA) database was searched for patients with asthma from 0 to 14 years old. A cross-sectional study with cost analysis was conducted. Results The annual per capita direct medical cost was RMB 525 (US$75) related to asthma. Totaling 58% of the medical expenditure for asthma was covered by insurance in China, the majority of which were direct medical costs. Those that have the highest rates of using antibiotics were central China (100.0%), children aged 3 years and under (63.6%), as well as fourth-tier and fifth-tier cities (77.1%). Outpatient clinics (98.58% vs 1.42%, P < 0.01), tertiary hospitals (62.08% vs 37.92%, P < 0.01), and general hospitals (72.27% vs 27.73%, P < 0.01) were more often visited than the inpatient clinics, secondary and primary as well as the specialized clinics, respectively. Conclusion The economic burden of childhood asthma in China is relatively low, and the national medical insurance reduces their economic burden to a large extent. Abuse of antibiotics in treating asthma was found in China. There remain opportunities to strengthen the hierarchical medical system, reducing hospitalization and emergency visits, and ultimately reducing the economic burden of children with asthma. Keywords: Childhood asthma, Economic burden, China medical insurance research association (CHIRA) database
Background At present, there are few studies on the economic burden and medical treatment of children with asthma in China. Thus this study aimed to investigate the economic burden of medical treatment of children with asthma in China. Method The 2015 China Medical Insurance Research Association (CHIRA) database was searched for patients with asthma from 0 to 14 years old. A cross-sectional study with cost analysis was conducted. Results The annual per capita direct medical cost was RMB 525 (US$75) related to asthma. Totaling 58% of the medical expenditure for asthma was covered by insurance in China, the majority of which were direct medical costs. Those that have the highest rates of using antibiotics were central China (100.0%), children aged 3 years and under (63.6%), as well as fourth-tier and fifth-tier cities (77.1%). Outpatient clinics (98.58% vs 1.42%, P < 0.01), tertiary hospitals (62.08% vs 37.92%, P < 0.01), and general hospitals (72.27% vs 27.73%, P < 0.01) were more often visited than the inpatient clinics, secondary and primary as well as the specialized clinics, respectively. Conclusion The economic burden of childhood asthma in China is relatively low, and the national medical insurance reduces their economic burden to a large extent. Abuse of antibiotics in treating asthma was found in China. There remain opportunities to strengthen the hierarchical medical system, reducing hospitalization and emergency visits, and ultimately reducing the economic burden of children with asthma.
ArticleNumber 386
Audience Academic
Author Zhang, Casper J. P.
Wu, Ping
Xu, Baoping
Shen, Kunling
Shen, Adong
Ming, Wai-kit
He, Zonglin
Author_xml – sequence: 1
  givenname: Ping
  surname: Wu
  fullname: Wu, Ping
– sequence: 2
  givenname: Baoping
  surname: Xu
  fullname: Xu, Baoping
– sequence: 3
  givenname: Adong
  surname: Shen
  fullname: Shen, Adong
– sequence: 4
  givenname: Zonglin
  surname: He
  fullname: He, Zonglin
– sequence: 5
  givenname: Casper J. P.
  surname: Zhang
  fullname: Zhang, Casper J. P.
– sequence: 6
  givenname: Wai-kit
  orcidid: 0000-0002-8846-7515
  surname: Ming
  fullname: Ming, Wai-kit
– sequence: 7
  givenname: Kunling
  orcidid: 0000-0002-1673-715X
  surname: Shen
  fullname: Shen, Kunling
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32811470$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1r3DAQhk1JaT7aP9BDMRRKL04l68u-FMKStAuBXtKzkCV5rcWWUklO6b_veDdpd0MpQsiMnnk9M3rPixMfvC2KtxhdYtzwTwnXTSMqVCPYNW8q_qI4w1TgqqYEnxx8nxbnKW0RwqKh_FVxSuoGwyU6K9Z3gy2tDj5MTpfdHI31ZejLyRqn1VjmaFWerM9LUA9uNBGAny4PpUp5mFTpfLkanFevi5e9GpN983heFN9vru9WX6vbb1_Wq6vbSrOW5opS0nYcE9URrnlPWmPajjErRCMwsqQRxhpGTUc6RPpWMcxEw7jFHUYtNEAuivVe1wS1lffRTSr-kkE5uQuEuJEqZqdHK2uqRUeRNoQyylrTUWF7w2uCai0Y46D1ea91P3fQsYY-oxqPRI9vvBvkJjxIQQlBjILAx0eBGH7MNmU5uaTtOCpvw5ygAsIYkGip-_0zdBvm6GFUO6pGIEn-UhsFDTjfB_ivXkTlFSe0JQ2QQF3-g4JlLDwjuKR3ED9K-HCQMFg15iGFcc4u-HQMvjucyJ9RPDkGgGYP6BhSiraX2mW16EAJbpQYycWccm9OCeaUO3PKZdr1s9Qn9f8k_QaoiOHQ
CitedBy_id crossref_primary_10_3389_fphar_2022_767917
crossref_primary_10_1155_2023_8783078
crossref_primary_10_1186_s12887_022_03720_5
crossref_primary_10_1186_s12890_023_02685_0
crossref_primary_10_2217_cer_2020_0080
crossref_primary_10_7759_cureus_60640
crossref_primary_10_1186_s13690_025_01515_5
crossref_primary_10_1371_journal_pone_0268717
crossref_primary_10_3389_fpubh_2021_649624
crossref_primary_10_3390_ijerph18126277
crossref_primary_10_1080_02770903_2024_2324855
crossref_primary_10_1155_2022_2005196
Cites_doi 10.1081/JAS-120002193
10.1183/09031936.02.00238202
10.1183/16000617.00003914
10.1056/NEJMoa1007302
10.1016/j.jaci.2014.05.012
10.1164/rccm.201110-1922OC
10.1503/cmaj.080612
10.1186/1471-2466-9-24
10.1016/S0140-6736(13)61536-6
10.1016/j.jval.2014.08.066
10.1097/PEC.0b013e3181db2262
10.1111/resp.12348
10.1164/rccm.200605-642ST
10.1353/hpu.2014.0051
10.5588/ijtld.14.0170
10.1111/resp.12196
10.1016/S0140-6736(11)61880-1
10.1111/resp.12901
10.3109/02770903.2014.999284
10.1016/j.anai.2011.04.008
10.1016/j.anai.2015.03.002
10.1016/j.jpeds.2013.05.002
10.1016/j.anai.2014.01.022
10.1016/j.jaci.2010.07.030
10.1111/pai.12669
10.1146/annurev-publhealth-031811-124532
10.1183/09031936.98.12061322
10.1097/ACI.0000000000000346
10.1016/j.pedneo.2013.07.004
10.1542/peds.2011-0218
10.1542/peds.2010-2092
10.1016/j.jaci.2011.12.968
10.1183/09031936.03.00052203
10.3109/02770903.2014.930882
10.1111/resp.13189
10.1183/09031936.00138707
10.1136/bmj.329.7464.486
ContentType Journal Article
Copyright COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2020
Copyright_xml – notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2020
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12887-020-02268-6
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE



Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2431
EndPage 11
ExternalDocumentID oai_doaj_org_article_24c7b40cd345459db47efd62302c7556
PMC7433054
A634938520
32811470
10_1186_s12887_020_02268_6
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations China
Cities
United States--US
GeographicLocations_xml – name: China
– name: Cities
– name: United States--US
GrantInformation_xml – fundername: National Key Research and Development Plan
  grantid: 2016YFC0901103
– fundername: ;
  grantid: 2016YFC0901103
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABUWG
ACGFO
ACGFS
ACIHN
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
IHW
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PMFND
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c594t-4439b613ab36c6f39dd9b55e778710e387ded54db3b03f9a5157856e1b1090173
IEDL.DBID M48
ISSN 1471-2431
IngestDate Wed Aug 27 01:19:48 EDT 2025
Thu Aug 21 18:08:57 EDT 2025
Tue Aug 05 10:03:58 EDT 2025
Fri Jul 25 06:16:49 EDT 2025
Tue Jun 17 21:28:18 EDT 2025
Tue Jun 10 20:33:26 EDT 2025
Thu May 22 21:19:42 EDT 2025
Mon Jul 21 05:56:31 EDT 2025
Tue Jul 01 01:20:10 EDT 2025
Thu Apr 24 23:02:05 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords China medical insurance research association (CHIRA) database
Economic burden
Childhood asthma
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c594t-4439b613ab36c6f39dd9b55e778710e387ded54db3b03f9a5157856e1b1090173
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-1673-715X
0000-0002-8846-7515
OpenAccessLink https://www.proquest.com/docview/2435204333?pq-origsite=%requestingapplication%
PMID 32811470
PQID 2435204333
PQPubID 42847
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_24c7b40cd345459db47efd62302c7556
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7433054
proquest_miscellaneous_2435530507
proquest_journals_2435204333
gale_infotracmisc_A634938520
gale_infotracacademiconefile_A634938520
gale_healthsolutions_A634938520
pubmed_primary_32811470
crossref_citationtrail_10_1186_s12887_020_02268_6
crossref_primary_10_1186_s12887_020_02268_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-08-18
PublicationDateYYYYMMDD 2020-08-18
PublicationDate_xml – month: 08
  year: 2020
  text: 2020-08-18
  day: 18
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC pediatrics
PublicationTitleAlternate BMC Pediatr
PublicationYear 2020
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References H Bisgaard (2268_CR37) 2012; 185
2268_CR48
J Serra-Batlles (2268_CR27) 1998; 12
T Wang (2268_CR7) 2014; 25
IM Paul (2268_CR29) 2011; 127
DK Radhakrishnan (2268_CR17) 2014; 134
SM Ho (2268_CR3) 2010; 126
W Murk (2268_CR31) 2011; 127
JF Knapp (2268_CR30) 2010; 26
M-S Ong (2268_CR33) 2014; 112
ZH Chen (2268_CR6) 2013; 18
AA Khan (2268_CR21) 2014; 51
LS Fu (2268_CR10) 2014; 55
Clinical, Institute LS (2268_CR41) 2009
SJ Szefler (2268_CR13) 2011; 107
NM Clark (2268_CR19) 2012; 33
A Kamps (2268_CR26) 2004; 23
NC Banasiak (2268_CR34) 2014; 40
N Su (2268_CR9) 2014; 53
B Ding (2268_CR14) 2018; 23
A James (2268_CR44) 2017; 28
FD Martinez (2268_CR2) 2013; 382
HJ Wu Jiaying (2268_CR45) 2018; 39
A Moeller (2268_CR39) 2015; 24
YZ Chen (2268_CR8) 2003; 41
GW Wong (2268_CR18) 2004; 329
ED Bateman (2268_CR5) 2008; 31
AM Butz (2268_CR40) 2015; 114
MJ Ege (2268_CR23) 2011; 364
R Mossing (2268_CR25) 2003; 165
L Owens (2268_CR38) 2017; 22
I Asher (2268_CR12) 2014; 18
K Hasegawa (2268_CR42) 2013; 163
JA Boyce (2268_CR1) 2012; 129
W Sun (2268_CR32) 2015; 52
XX Jie Liang (2268_CR47) 2017; 30
P Subbarao (2268_CR22) 2009; 181
LM Pachter (2268_CR11) 2002; 39
NJR Berend (2268_CR35) 2014; 19
E Valovirta (2268_CR28) 2002; 20
AB Becker (2268_CR46) 2017; 17
WC Yip (2268_CR15) 2012; 379
FJ Gilchrist (2268_CR24) 2012; 1
N Beydon (2268_CR36) 2007; 175
Y Yang (2268_CR16) 2014; 17
K Bahadori (2268_CR4) 2009; 9
G Mustafa (2268_CR20) 2008; 20
B Chastek (2268_CR43) 2016; 22
References_xml – volume: 39
  start-page: 119
  issue: 2
  year: 2002
  ident: 2268_CR11
  publication-title: J Asthma
  doi: 10.1081/JAS-120002193
– volume: 20
  start-page: 397
  issue: 2
  year: 2002
  ident: 2268_CR28
  publication-title: Eur Respir J
  doi: 10.1183/09031936.02.00238202
– volume: 24
  start-page: 204
  issue: 136
  year: 2015
  ident: 2268_CR39
  publication-title: Eur Respir Rev
  doi: 10.1183/16000617.00003914
– volume: 22
  start-page: 848
  issue: 7
  year: 2016
  ident: 2268_CR43
  publication-title: J Manag Care Spec Pharm
– volume: 364
  start-page: 701
  issue: 8
  year: 2011
  ident: 2268_CR23
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1007302
– volume: 134
  start-page: 1057
  issue: 5
  year: 2014
  ident: 2268_CR17
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2014.05.012
– volume: 185
  start-page: 1183
  issue: 11
  year: 2012
  ident: 2268_CR37
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201110-1922OC
– volume: 181
  start-page: E181
  issue: 9
  year: 2009
  ident: 2268_CR22
  publication-title: CMAJ
  doi: 10.1503/cmaj.080612
– volume: 39
  start-page: 512
  issue: 8
  year: 2018
  ident: 2268_CR45
  publication-title: World Clin Drugs
– volume: 9
  start-page: 24
  issue: 9
  year: 2009
  ident: 2268_CR4
  publication-title: BMC Pulm Med
  doi: 10.1186/1471-2466-9-24
– volume: 382
  start-page: 1360
  issue: 9901
  year: 2013
  ident: 2268_CR2
  publication-title: Lancet
  doi: 10.1016/S0140-6736(13)61536-6
– volume: 17
  start-page: A728
  issue: 7
  year: 2014
  ident: 2268_CR16
  publication-title: Value Health
  doi: 10.1016/j.jval.2014.08.066
– volume-title: Performance standards for antimicrobial susceptibility testing of anaerobic bacteria: informational supplement: Clinical and Laboratory Standards Institute (CLSI)
  year: 2009
  ident: 2268_CR41
– volume: 30
  start-page: 22
  issue: 11
  year: 2017
  ident: 2268_CR47
  publication-title: Med Soc
– volume: 165
  start-page: 2646
  issue: 26
  year: 2003
  ident: 2268_CR25
  publication-title: Ugeskr Laeger
– volume: 40
  start-page: 195
  issue: 4
  year: 2014
  ident: 2268_CR34
  publication-title: Pediatr Nurs
– volume: 26
  start-page: 364
  issue: 5
  year: 2010
  ident: 2268_CR30
  publication-title: Pediatr Emerg Care
  doi: 10.1097/PEC.0b013e3181db2262
– volume: 19
  start-page: 952
  issue: 7
  year: 2014
  ident: 2268_CR35
  publication-title: Respirology
  doi: 10.1111/resp.12348
– volume: 175
  start-page: 1304
  issue: 12
  year: 2007
  ident: 2268_CR36
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200605-642ST
– volume: 25
  start-page: 396
  issue: 1
  year: 2014
  ident: 2268_CR7
  publication-title: J Health Care Poor Underserved
  doi: 10.1353/hpu.2014.0051
– volume: 18
  start-page: 1269
  issue: 11
  year: 2014
  ident: 2268_CR12
  publication-title: Int J Tuberc Lung Dis
  doi: 10.5588/ijtld.14.0170
– volume: 18
  start-page: 10
  year: 2013
  ident: 2268_CR6
  publication-title: Respirology
  doi: 10.1111/resp.12196
– volume: 379
  start-page: 833
  issue: 9818
  year: 2012
  ident: 2268_CR15
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)61880-1
– volume: 22
  start-page: 289
  issue: 2
  year: 2017
  ident: 2268_CR38
  publication-title: Respirology
  doi: 10.1111/resp.12901
– volume: 52
  start-page: 647
  issue: 7
  year: 2015
  ident: 2268_CR32
  publication-title: J Asthma
  doi: 10.3109/02770903.2014.999284
– volume: 107
  start-page: 110
  issue: 2
  year: 2011
  ident: 2268_CR13
  publication-title: Ann Allergy Asthma Immunol
  doi: 10.1016/j.anai.2011.04.008
– volume: 114
  start-page: 385
  issue: 5
  year: 2015
  ident: 2268_CR40
  publication-title: Ann Allergy Asthma Immunol
  doi: 10.1016/j.anai.2015.03.002
– volume: 163
  start-page: 1127
  issue: 4
  year: 2013
  ident: 2268_CR42
  publication-title: J Pediatr
  doi: 10.1016/j.jpeds.2013.05.002
– volume: 112
  start-page: 441
  issue: 5
  year: 2014
  ident: 2268_CR33
  publication-title: Ann Allergy Asthma Immunol
  doi: 10.1016/j.anai.2014.01.022
– volume: 126
  start-page: 453
  issue: 3
  year: 2010
  ident: 2268_CR3
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2010.07.030
– volume: 28
  start-page: 79
  issue: 1
  year: 2017
  ident: 2268_CR44
  publication-title: Pediatr Allergy Immunol
  doi: 10.1111/pai.12669
– volume: 33
  start-page: 193
  year: 2012
  ident: 2268_CR19
  publication-title: Annu Rev Public Health
  doi: 10.1146/annurev-publhealth-031811-124532
– volume: 12
  start-page: 1322
  issue: 6
  year: 1998
  ident: 2268_CR27
  publication-title: Eur Respir J
  doi: 10.1183/09031936.98.12061322
– volume: 17
  start-page: 99
  issue: 2
  year: 2017
  ident: 2268_CR46
  publication-title: Curr Opin Allergy Clin Immunol
  doi: 10.1097/ACI.0000000000000346
– volume: 55
  start-page: 83
  issue: 2
  year: 2014
  ident: 2268_CR10
  publication-title: Pediatr Neonatol
  doi: 10.1016/j.pedneo.2013.07.004
– volume: 127
  start-page: 1014
  issue: 6
  year: 2011
  ident: 2268_CR29
  publication-title: Pediatrics
  doi: 10.1542/peds.2011-0218
– volume: 127
  start-page: 1125
  issue: 6
  year: 2011
  ident: 2268_CR31
  publication-title: Pediatrics
  doi: 10.1542/peds.2010-2092
– volume: 129
  start-page: 335
  issue: 2
  year: 2012
  ident: 2268_CR1
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2011.12.968
– ident: 2268_CR48
– volume: 53
  start-page: 601
  issue: 8
  year: 2014
  ident: 2268_CR9
  publication-title: Zhonghua Er Ke Za Zhi
– volume: 23
  start-page: 304
  issue: 2
  year: 2004
  ident: 2268_CR26
  publication-title: Eur Respir J
  doi: 10.1183/09031936.03.00052203
– volume: 51
  start-page: 891
  issue: 9
  year: 2014
  ident: 2268_CR21
  publication-title: J Asthma
  doi: 10.3109/02770903.2014.930882
– volume: 23
  start-page: 369
  issue: 4
  year: 2018
  ident: 2268_CR14
  publication-title: Respirology
  doi: 10.1111/resp.13189
– volume: 41
  start-page: 123
  issue: 2
  year: 2003
  ident: 2268_CR8
  publication-title: Zhonghua Er Ke Za Zhi
– volume: 20
  start-page: 36
  issue: 3
  year: 2008
  ident: 2268_CR20
  publication-title: J Ayub Med Coll Abbottabad
– volume: 31
  start-page: 143
  issue: 1
  year: 2008
  ident: 2268_CR5
  publication-title: Eur Respir J
  doi: 10.1183/09031936.00138707
– volume: 1
  start-page: 56
  year: 2012
  ident: 2268_CR24
  publication-title: Eur Respir Monograph
– volume: 329
  start-page: 486
  issue: 7464
  year: 2004
  ident: 2268_CR18
  publication-title: BMJ
  doi: 10.1136/bmj.329.7464.486
SSID ssj0017846
Score 2.3245811
Snippet At present, there are few studies on the economic burden and medical treatment of children with asthma in China. Thus this study aimed to investigate the...
Background At present, there are few studies on the economic burden and medical treatment of children with asthma in China. Thus this study aimed to...
Abstract Background At present, there are few studies on the economic burden and medical treatment of children with asthma in China. Thus this study aimed to...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 386
SubjectTerms Adolescent
Age groups
Allergens
Ambulatory care facilities
Analysis
Antibiotics
Asthma
Asthma - drug therapy
Child
Child, Preschool
Childhood asthma
Children
China - epidemiology
China medical insurance research association (CHIRA) database
Chronic illnesses
Cities
Cost of Illness
Costs
Cross-Sectional Studies
Economic aspects
Economic burden
Health insurance
Health insurance industry
Hematology
Hospitals
Humans
Infant
Infant, Newborn
Medical economics
National health insurance
Patients
Pediatrics
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3La9ZAEB-kB_EiWl_RVlcQPEhosu8cq1iqUE8WeluyL1qw-cTv6__v7CPhC4JevGYnIZmdZ3bmNwDvoosYJbjUfkZjy4VFO-icQ2Po0durPto8ReHimzy_5F-vxNXeqK9UE1bggQvjTih3yvLOecbR2Q_echWiR6fdUaeEyGDb6PPmZKqeHyh0q3OLjJYnW7TCqEwpVUKfJXUrV24oo_X_aZP3nNK6YHLPA509goc1dCSn5ZUfw70wHcL9i3o4_gS-4JaTUBuNic39CWQTyW05iyFLTXm6ODdxk_Qjlozb3fXtSG4mkudpP4XLs8_fP523dVJC68TAdy3HsMKiYx4tk05GNng_WCGCQnXsu8C08sEL7i2zHYvDiEGM0kKG3qa6zF6xZ3AwbabwAggGBDKiFdSKes4kx-Q54Qek80WqRhob6GfGGVdhxNM0ix8mpxNamsJsg8w2mdlGNvBhuednAdH4K_XHtB8LZQLAzhdQLEwVC_MvsWjgTdpNU7pJFzU2p5LxgWlBuwbeZ4qkyPgBbqz9CMiGBIm1ojxaUaICuvXyLDGmGoAtvh9GtgkcjjXwdllOd6aitils7gqNQHvbqQaeFwFbPppRjZmqwoerleituLJemW6uMzw4xoT4UP7yf7DxFTygWWt02-sjONj9ugvHGIXt7OuscL8BQoQo6A
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1ba9YwNOgE8WXMe3VqBMEHKWuba59kjo0pzCcH31tobm6wtXPft_-_c9K0WxH22pyE5uRck3Mh5Et0EawEh-lnTSy5sCAHnXMgDD1oe1VHm7oonPyWx6f810qs8oXbOodVTjIxCWo_OLwj32tAr2MeJ2Pfr_6V2DUKX1dzC43H5AmWLkOqVqvZ4aoVKNcpUUbLvTXIYmApdJhAc0ldyoUySjX7_5fM91TTMmzynh462iHb2YCk--OJPyePQv-CPD3JT-QvyU84eBpyujG1KUuBDpFeji8ydI4sx49TKjfF61jarTdnlx0972nqqv2KnB4d_jk4LnO_hNKJlm9KDsaFBfXcWSadjKz1vrVCBAVMWVeBaeWDF9xbZisW2w5MGaWFDLXF6Mxasddkqx_68JZQMAtkBFmoVeM5kxxcaKwigK-MjeqaWJB6QpxxuZg49rS4MMmp0NKMyDaAbJOQbWRBvs1zrsZSGg9C_8DzmCGxDHb6MFz_NZmrTMOdsrxynnGwBFtvuQrRg0VXNU4JAYt8wtM0Y07pzMxmXzLeMg0EVZCvCQLZGTbgupyVAGjAwlgLyN0FJLChWw5PFGOyGFibO6ItyOd5GGdiaFsfhpsRRoDUrVRB3owENm-aNRr8VQWLqwXpLbCyHOnPz1KRcLAMYVH-7uHfek-eNYkfdFnrXbK1ub4JH8DK2tiPiZVuAW6GIPo
  priority: 102
  providerName: ProQuest
Title The economic burden of medical treatment of children with asthma in China
URI https://www.ncbi.nlm.nih.gov/pubmed/32811470
https://www.proquest.com/docview/2435204333
https://www.proquest.com/docview/2435530507
https://pubmed.ncbi.nlm.nih.gov/PMC7433054
https://doaj.org/article/24c7b40cd345459db47efd62302c7556
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9RAFB56AfFFvBut6wiCDxJN5p4Hka60VGGLFBcWX4bMrS20Wd3dgv57z0wuNlj6kofMyZCcnMt3Zuacg9CbYAOgBBvTz0jIGTdgB621YAwdeHtZBpO6KMyOxdGcfV3wxRbq2x11DFzfGNrFflLz1cX737_-fAKF_5gUXokPa7CxoCoxEAKPJFQuttEueCYZOxrM2L9dBam6bCNZ5gQ8Z59Ec-McI0eV6vn_b7Wvua3xkcprPurwPrrXgUu830rDA7Tlm4fozqzbPn-EvoBQYN-lImOTMhjwMuDLdrcGD6fO480-zRvHpVpcrzdnlzU-b3DquP0YzQ8Pvn8-yrteCrnlFdvkDICHAdddGyqsCLRyrjKcewkKWxaeKum848wZagoaqhpgjlRc-NLEk5ulpE_QTrNs_DOEATKIAHZSSeIYFQzC61hhIO5AElmTkKGyZ5y2XaHx2O_iQqeAQwndMlsDs3VithYZejc887Mts3Er9TT-j4EylshON5arU91pnCbMSsMK6ygDlFg5w6QPDtBeQazkHCZ5Ff-mbvNNB0XX-4KyiipOigy9TRRR-OADbN1lLAAbYtGsEeXeiBJU1I6He4nRvYTD-wH2jeXjaIZeD8PxyXjsrfHLq5aGg0UuZIaetgI2fDQlCmJZCZPLkeiNuDIeac7PUgFxQI0wKXt--1u_QHdJ0geVl2oP7WxWV_4lILCNmaBtuZATtDs9OP52MknrGJOkanA9mf74C-MUKlM
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkYAL4s1CoUYCcUBREz-TA0LlUe3Sbk-ttDcTP0IrtUnb3Qrxp_iNzDgPGiH11ms8sZLxzHwztmeGkLeVq8BLcJh-xqpESAt20DkHxtAD2uussrGLwnxfTQ_F94VcrJE_fS4MXqvsbWI01L5xuEe-xQDXMY-T809n5wl2jcLT1b6FRisWu-H3LwjZlh9nX2F93zG28-3gyzTpugokThZilQiAYAsgVlqunKp44X1hpQwaRDdLA8-1D14Kb7lNeVWUAPg6lypkFu8wZprDvLfIbQDeFIM9vRgCvEwDmPeJObnaWoLtBxXGAA2QUuWJGoFf7BHwPxJcgcLxNc0ruLfzgNzvHFa63UrYQ7IW6kfkzrw7kn9MZiBoNHTpzdTGrAjaVPS0PQGiw012fNinjlPc_qXlcnV0WtLjmsYu3k_I4Y1w8ilZr5s6PCcU3BBVge3NNfOCKwEhO1YtwFNNpktWTUjWM864rng59tA4MTGIyZVpmW2A2SYy26gJ-TC8c9aW7riW-jOux0CJZbfjg-bip-m02DDhtBWp81yA51l4K3SoPHiQKXNaSphkE1fTtDmsg_Ew24qLgucgwBPyPlKg-YAfcGWXBQFswEJcI8qNESWovRsP9xJjOrOzNP-UZELeDMP4Jl6lq0Nz2dJIsPKpnpBnrYANP81ZDvGxhsn1SPRGXBmP1MdHsSg5eKIwqXhx_WdtkrvTg_me2Zvt774k91jUjTzJ8g2yvrq4DK_Aw1vZ11GtKPlx03r8F8WTXD0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+economic+burden+of+medical+treatment+of+children+with+asthma+in+China&rft.jtitle=BMC+pediatrics&rft.au=Wu%2C+Ping&rft.au=Xu%2C+Baoping&rft.au=Shen%2C+Adong&rft.au=He%2C+Zonglin&rft.date=2020-08-18&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2431&rft.eissn=1471-2431&rft.volume=20&rft.issue=1&rft_id=info:doi/10.1186%2Fs12887-020-02268-6&rft.externalDocID=A634938520
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2431&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2431&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2431&client=summon